Статті в журналах: "COVID-19 – complications"

1

H Jagtap Priya, Abhishek. "Post-Acute COVID-19 Complications." International Journal of Science and Research (IJSR) 12, no. 6 (June 5, 2023): 863–65. http://dx.doi.org/10.21275/sr23413205037.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

De Michele, Manuela, Joshua Kahan, Irene Berto, Oscar G. Schiavo, Marta Iacobucci, Danilo Toni, and Alexander E. Merkler. "Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination." Circulation Research 130, no. 8 (April 15, 2022): 1187–203. http://dx.doi.org/10.1161/circresaha.122.319954.

Повний текст джерела

Анотація:

The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has been extensively reported since the onset of the pandemic. The striking efforts of many scientists in cooperation with regulators and governments worldwide have rapidly brought the development of a large landscape of vaccines against SARS-CoV-2. The novel DNA and mRNA vaccines have offered great flexibility in terms of antigen production and led to an unprecedented rapidity in effective and safe vaccine production. However, as mass vaccination has progressed, rare but catastrophic cases of thrombosis have occurred in association with thrombocytopenia and antibodies against PF4 (platelet factor 4). This catastrophic syndrome has been named vaccine-induced immune thrombotic thrombocytopenia. Rarely, ischemic stroke can be the symptom onset of vaccine-induced immune thrombotic thrombocytopenia or can complicate the course of the disease. In this review, we provide an overview of stroke and cerebrovascular disease as a complication of the SARS-CoV-2 infection and outline the main clinical and radiological characteristics of cerebrovascular complications of vaccinations, with a focus on vaccine-induced immune thrombotic thrombocytopenia. Based on the available data from the literature and from our experience, we propose a therapeutic protocol to manage this challenging condition. Finally, we highlight the overlapping pathophysiologic mechanisms of SARS-CoV-2 infection and vaccination leading to thrombosis.

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Prasanthi, K. "Post COVID 19 Vaccination Associated Neurological Complications." International Journal of Science and Research (IJSR) 12, no. 7 (July 5, 2023): 2136–40. http://dx.doi.org/10.21275/mr23727093509.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Kim, Geun-Jeon, and Young-Hoon Joo. "Laryngeal Complications of the COVID-19." Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics 33, no. 3 (December 31, 2022): 156–59. http://dx.doi.org/10.22469/jkslp.2022.33.3.156.

Повний текст джерела

Анотація:

The coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus-2 has upended the world of otolaryngology. After COVID-19 infection, patients experience various complication of symptoms due to injury of the larynx and lung/ respiratory system. Regardless of the patient’s severity, patients can experience several complications including dysphonia, vocal cord paralysis/paresis and sensory neuropathy. An emerging role for otolaryngologists in the coming weeks and months is the management of laryngeal complications of COVID-19. This review is intended to describe laryngeal complications in patients recovering from COVID-19 infection.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Pařízek, Petr. "Cardiovascular complications and covid-19 infection." Intervenční a akutní kardiologie 20, no. 2 (July 9, 2021): 78–80. http://dx.doi.org/10.36290/kar.2021.024.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Billah, Syed Muhammad Baqui, Jannatul Ferdous, A. K. M. Akbar Kabir, Farzana Ferdous Munmun, Indrani Kar, and Sabrina Tymee. "Post-COVID-19 Complications and Associated Factors among COVID-19 Survivors in Southern Part of Bangladesh." European Journal of Medical and Health Sciences 6, no. 5 (October 6, 2024): 49–52. http://dx.doi.org/10.24018/ejmed.2024.6.5.2170.

Повний текст джерела

Анотація:

Objective: SARS-CoV-2 infection causes numerous post-COVID (COV) complications among patients after recovery. Materials and Methods: This cross-sectional study was conducted at Sher-E-Bangla Medical College (SBMC), Barishal, Bangladesh, on 773 SARS-CoV-2 survivors from February to June 2021. Baseline characteristics, including comorbidity and post-COVID complications, were assessed. Results: The prevalence of post-COV complications was 22.8% (95% CI: 19.9%–25.9%). Fatigue (18.2%) was the most common complication, followed by shortness of breath (14.6%), cough (11.1%), chest pain (6.5%) and body ache (5.4%). Bronchial asthma (OR = 2.38), diabetes mellitus (OR = 2.07), Business and service (OR = 1.82), Good education (OR = 2.91), and tobacco use (OR = 1.40) were among the significant factors associated with the post-COV complications while hypertension and residence could not produce significant odds of association, though they were associated in the preliminary analysis. Conclusion: COVID-19 is associated with many complications involving all systems of the body. Certain comorbidities and demographic factors are associated with post-COV complications. The factors should be addressed in advance if the infection emerges again in the future.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Hasan, Sameer Ibrahim, Imad A. Thanoon, Abdul-rahman I. A-J Thanoon, Omar SI Hasan, and Rwqaya S. Dawood. "Complications after Covid-19 vaccination." Annals of the College of Medicine, Mosul 44, no. 1 (June 1, 2022): 88–94. http://dx.doi.org/10.33899/mmed.2022.134076.1151.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Baysal-Kirac, Leyla, and Hilmi Uysal. "COVID-19 associate neurological complications." Neurological Sciences and Neurophysiology 37, no. 1 (2020): 1. http://dx.doi.org/10.4103/nsn.nsn_28_20.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Venkataramana, NK. "Cerebrovascular complications of COVID-19." Journal of Cerebrovascular Sciences 8, no. 1 (2020): 2. http://dx.doi.org/10.4103/jcvs.jcvs_13_20.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Rahkmonova, Sanobar, Jurabek Khaytboyev, Nargiza Zargarova, Dilfuza Otajonova, and Khabibulla Kazakov. "Kidney complications after COVID-19." International journal of health sciences 5, no. 3 (November 1, 2021): 393–402. http://dx.doi.org/10.53730/ijhs.v5n3.1698.

Повний текст джерела

Анотація:

This article discusses renal complications after Covid-19. It has now become clear that infection with the SARS-Cov-2 virus, which causes COVID-19, is almost identical - and this tells scientists which organs are most at risk. Specifically, the respiratory tract, intestines and, most likely, the kidneys, since it is there that both proteins necessary for the virus are present. Even the Ebola virus, found in the eye fluid of ex-patient’s months after recovery, causes blindness in 40 percent of those infected later. Therefore, given that SARS-CoV-2 is more likely to damage the lungs, doctors have speculated that the virus may cause irreversible changes in the respiratory system.

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Maslove, David M., Stephanie Sibley, J. Gordon Boyd, Ewan C. Goligher, Laveena Munshi, Isaac I. Bogoch, and Bram Rochwerg. "Complications of Critical COVID-19." Chest 161, no. 4 (April 2022): 989–98. http://dx.doi.org/10.1016/j.chest.2021.10.011.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Al-Jahdhami, Issa, Khalid Al-naamani, Adhra Al-Mawali, and Sami M. Bennji. "Respiratory Complications after COVID-19." Oman Medical Journal 37, no. 1 (January 31, 2022): e343-e343. http://dx.doi.org/10.5001/omj.2022.52.

Повний текст джерела

Анотація:

COVID-19 pandemic has been associated with high short-term morbidity and mortality. Lungs are the main organs affected by SARS-CoV-2 infection. In the long-term, the pulmonary sequelae related to COVID-19 are expected to rise significantly leading to an extended impact on community health and health care facilities. A wide variety of long-term respiratory complications secondary to COVID-19 have been described ranging from persistent symptoms and radiologically observable changes to impaired respiratory physiology, vascular complications, and pulmonary fibrosis. Even after two-years, respiratory sequalae related to post-acute SARS-CoV-2 infection have not been fully explored and understood. The main treatment for most COVID-19 respiratory complications is still symptomatic and supportive-care oriented. In this review article, we shed light on current knowledge of the post-COVID-19 complications, focusing on pulmonary fibrosis, treatment directions, and recommendations to physicians.

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Lee, Clement C. E., Kashan Ali, David Connell, Ify R. Mordi, Jacob George, Elizabeth MSL Lang, and Chim C. Lang. "COVID-19-Associated Cardiovascular Complications." Diseases 9, no. 3 (June 29, 2021): 47. http://dx.doi.org/10.3390/diseases9030047.

Повний текст джерела

Анотація:

Coronavirus disease 2019 (COVID-19) has been reported to cause cardiovascular complications such as myocardial injury, thromboembolic events, arrhythmia, and heart failure. Multiple mechanisms—some overlapping, notably the role of inflammation and IL-6—potentially underlie these complications. The reported cardiac injury may be a result of direct viral invasion of cardiomyocytes with consequent unopposed effects of angiotensin II, increased metabolic demand, immune activation, or microvascular dysfunction. Thromboembolic events have been widely reported in both the venous and arterial systems that have attracted intense interest in the underlying mechanisms. These could potentially be due to endothelial dysfunction secondary to direct viral invasion or inflammation. Additionally, thromboembolic events may also be a consequence of an attempt by the immune system to contain the infection through immunothrombosis and neutrophil extracellular traps. Cardiac arrhythmias have also been reported with a wide range of implicated contributory factors, ranging from direct viral myocardial injury, as well as other factors, including at-risk individuals with underlying inherited arrhythmia syndromes. Heart failure may also occur as a progression from cardiac injury, precipitation secondary to the initiation or withdrawal of certain drugs, or the accumulation of des-Arg9-bradykinin (DABK) with excessive induction of pro-inflammatory G protein coupled receptor B1 (BK1). The presenting cardiovascular symptoms include chest pain, dyspnoea, and palpitations. There is currently intense interest in vaccine-induced thrombosis and in the treatment of Long COVID since many patients who have survived COVID-19 describe persisting health problems. This review will summarise the proposed physiological mechanisms of COVID-19-associated cardiovascular complications.

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Camelia, DIACONU. "Cardiovascular complications of COVID-19." Archives of the Balkan Medical Union 56, no. 2 (June 20, 2021): 139–41. http://dx.doi.org/10.31688/abmu.2021.56.2.139.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Newcombe, Virginia F. J., Neha S. Dangayach, and Romain Sonneville. "Neurological complications of COVID-19." Intensive Care Medicine 47, no. 9 (June 7, 2021): 1021–23. http://dx.doi.org/10.1007/s00134-021-06439-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Zacharias, Hannah, Shirish Dubey, Gouri Koduri, and David D'Cruz. "Rheumatological complications of Covid 19." Autoimmunity Reviews 20, no. 9 (September 2021): 102883. http://dx.doi.org/10.1016/j.autrev.2021.102883.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Trufanov, Y. O. "NEUROLOGICAL COMPLICATIONS OF COVID-19." East European Journal of Parkinson`s Disease and Movement Disorders 6, no. 3-4 (December 30, 2020): 3–7. http://dx.doi.org/10.33444/2414-0007.6.3-4.3-7.

Повний текст джерела

Анотація:

After the first cases of the new disease COVID-19 (caused by the SARS-CoV-2 coronavirus) were registered in Wuhan, China in December 2019, its spread rapidly became a pandemic and within a few months it covered almost 200 countries [6]. The global COVID-19 pandemic has infected more than 79 million people around the world and claimed more than 1.7 million lives as of December 24, 2020 (according to the Center for Systems Science and Engineering at Johns Hopkins University). Thus, the mortality rate is 2.2%, which significantly exceeds the mortality rate for influenza. It is believed that the peak of the COVID-19 pandemic will continue in the next few months, after which the pandemic will decline. Although the predominant manifestations of COVID-19 are respiratory symptoms, more and more attention is paid to neurological complications. Some neurological complications are potentially life-threatening and can lead to death. The most common neurological complications of acute phase of COVID-19 are impairments of olfaction and taste, which are observed in 33-88% of patients [3]. These symptoms are important for differential diagnosis with influenza and ARVI viruses. Headaches, dizziness, fatigue, and myalgia according to different studies can be observed in 6.5-16.8% of patients. Other neurological complications of COVID-19 often develop in severe and very severe disease (although there are exceptions). Apparently, such neurological complications as ischemic stroke, transient ischemic attack, encephalopathy, delirium can be observed in approximately 0.5-3% of patients. Even less common are hemorrhagic stroke, venous sinus thrombosis, meningitis, encephalitis, encephalomyelitis, cerebral vasculitis, III, V, VI, VII, VIII, IX cranial nerves lesions, Guillain-Barre syndrome, Miller-Fisher syndrome, polyneuropathy, acute dysautonomia, myopathy, myoclonus, epileptic seizures and status epilepticus [2, 4-8]. Awareness of the neurological complications of COVID-19 can influence treatment strategies and simultaneously improve the prognosis for critically ill patients [5]. Keywords: COVID-19, SARS-CoV-2, coronavirus, neurological complications

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Jakubec, Petr, Kateřina Fišerová, Samuel Genzor, and Milan Kolář. "Pulmonary Complications after COVID-19." Life 12, no. 3 (February 28, 2022): 357. http://dx.doi.org/10.3390/life12030357.

Повний текст джерела

Анотація:

Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5–11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%.

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Marinho Silva de Souza, Mateus, Matheus Araújo de Oliveira Farias, Ana Rita de Oliveira Souza da Silva, Nataly Regina Fonseca Carvalho de Medeiros, and Marcelo Moraes Valença. "Neurological complications of Covid-19:." Jornal Memorial da Medicina 2, no. 1 (November 30, 2020): 29–37. http://dx.doi.org/10.37085/jmmv2.n1.2020.pp.29-37.

Повний текст джерела

Анотація:

A pandemia causada pelo novo coronavírus trouxe consigo grandes desafios para a ciência visto sua alta taxa de transmissão, que gera uma crise nos sistemas de saúde e econômicos de todo o mundo e exige respostas rápidas por parte dos pesquisadores. Sabemos que o receptor para enzima conversora de angiotensina 2 desempenha um papel importante na infecção. Esse receptor também está presente em neurônios e células gliais do córtex motor, porção posterior do giro do cíngulo, paredes dos ventrículos, substância negra, bulbo olfatório, giro temporal médio, núcleo do trato solitário, medula ventrolateral e núcleo dorsal do vago. Motivo pelo qual o mecanismo de neuroinvasão precisa ser melhor crompreendido. Suas manifestações neurológicas podem, muitas vezes, se apresentar na forma de sintomas leves, como hiposmia e ageusia. A partir de revisão da literatura, neste artigo investigamos as repercussões neurológicas da infecção pelo vírus em que foram estudadas as consequências da Covid-19 no sistema nervoso central, a resposta inflamatória causada por sua presença e o estado de hipercoagulabilidade, bem como a forma pela qual se desencadeiam as complicações, desde uma cefaleia até uma encefalopatia ou acidente vascular cerebral.

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Hassett, Catherine E., Aron Gedansky, Ibrahim Migdady, Adarsh Bhimraj, Ken Uchino, and Sung-Min Cho. "Neurologic complications of COVID-19." Cleveland Clinic Journal of Medicine 87, no. 12 (August 26, 2020): 729–34. http://dx.doi.org/10.3949/ccjm.87a.ccc058.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Kozlov, I. A., and I. N. Tyurin. "Cardiovascular complications of COVID-19." Messenger of ANESTHESIOLOGY AND RESUSCITATION 17, no. 4 (September 4, 2020): 14–22. http://dx.doi.org/10.21292/2078-5658-2020-17-4-14-22.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Ashraf, Obaid, Meilin Young, Khalid J. Malik, and Tariq Cheema. "Systemic Complications of COVID-19." Critical Care Nursing Quarterly 43, no. 4 (October 2020): 390–99. http://dx.doi.org/10.1097/cnq.0000000000000324.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Pinto, FaustoJ, Joana Brito, BeatrizValente Silva, PedroAlves da Silva, Nuno Cortez-Dias, Doroteia Silva, JoãoR Agostinho, Tatiana Guimar, and Dulce Brito. "Cardiovascular complications of COVID-19." Heart and Mind 4, no. 3 (2020): 67. http://dx.doi.org/10.4103/hm.hm_28_20.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Baron, Madeleine, Olivia Sherwen, Paul Anthony Heaton, and Siba Prosad Paul. "COVID-19 complications in children." British Journal of Nursing 29, no. 20 (November 12, 2020): 1146. http://dx.doi.org/10.12968/bjon.2020.29.20.1146.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Long, Brit, William J. Brady, Alex Koyfman, and Michael Gottlieb. "Cardiovascular complications in COVID-19." American Journal of Emergency Medicine 38, no. 7 (July 2020): 1504–7. http://dx.doi.org/10.1016/j.ajem.2020.04.048.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Bridwell, Rachel, Brit Long, and Michael Gottlieb. "Neurologic complications of COVID-19." American Journal of Emergency Medicine 38, no. 7 (July 2020): 1549.e3–1549.e7. http://dx.doi.org/10.1016/j.ajem.2020.05.024.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Avila, Jacob, Brit Long, Dallas Holladay, and Michael Gottlieb. "Thrombotic complications of COVID-19." American Journal of Emergency Medicine 39 (January 2021): 213–18. http://dx.doi.org/10.1016/j.ajem.2020.09.065.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Naunheim, Matthew R., Allen S. Zhou, Elefteria Puka, Ramon A. Franco, Thomas L. Carroll, Stephanie E. Teng, Pavan S. Mallur, and Phillip C. Song. "Laryngeal complications of COVID ‐19." Laryngoscope Investigative Otolaryngology 5, no. 6 (October 30, 2020): 1117–24. http://dx.doi.org/10.1002/lio2.484.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Gill, Christine, and Tracey A. Cho. "Neurologic Complications of COVID-19." CONTINUUM: Lifelong Learning in Neurology 29, no. 3 (June 2023): 946–65. http://dx.doi.org/10.1212/con.0000000000001272.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Gois, Claudia Patricia da Silva, Ana Paula Macedo Prudente de Queiroz, and Renan Remaeh Rocca. "Chronic complications after COVID-19." JOURNAL OF RESEARCH AND KNOWLEDGE SPREADING 4, no. 1 (April 17, 2023): e13776. http://dx.doi.org/10.20952/jrks4113776.

Повний текст джерела

Анотація:

COVID-19 can develop persistent sequelae that can last from weeks to months after initial recovery. Post-COVID syndrome was defined as symptoms persisting for more than 12 weeks after recovery from the acute condition. This integrative review aims to identify the long-term effects of COVID-19, assisting in the recognition and management of its complications, as well as relating these to its main impacts on Public Health. Works with original data on digital platforms were searched and 2721 articles were identified, of which 37 met the inclusion criteria. Among the various symptoms mentioned in the analyzed studies, the five most prevalent were fatigue (34), dyspnea (34), headache (31), myalgia (28) and cough(27). Memory loss, cognitive deficit, concentration deficit and brain fog were persistent symptoms used separately in some articles, difficult to distinguish by the patients themselves, being encompassed in a set of neurological alterations. Female gender and the severity of the acute illness have been identified as risk factors for the development of post-COVID syndrome, however, patients who were not hospitalized may also have persistent symptoms. Multidisciplinary teams are crucial to develop preventive measures, rehabilitation techniques, and clinical management strategies with a whole-patient perspective designed to address the long-term care of COVID-19. Therefore, Primary Health Care is a fundamental strategy for both the containment of the pandemic and for the non-aggravation of people with COVID-19. In addition, immunization actions make up the set of prevention activities developed by primary care teams, which are of paramount importance.

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Bila, N. V., M. S. Brynza, and N. V. Tytarenko. "Cardiovascular complications of COVID-19." 48, no. 48 (March 29, 2024): 86–97. http://dx.doi.org/10.26565/2313-6693-2024-48-09.

Повний текст джерела

Анотація:

Background. The problem of COVID-19 today is the most unresolved worldwide. Scientists and doctors all over the world are trying to study features of pathogenesis this disease to find the most effective treatment methods. Multiple organ complications COVID-19 lead to death and disability of patients. The disease manifests itself with symptoms of damage to the pulmonary system with subsequent damage other systems and organs. Considering that cardiovascular diseases remain the leading cause of death worldwide, it is necessary to study the features of flow COVID-19 against the background of existing cardiovascular pathology. Purpose – the purpose of the study was to analyze and summarize literature sources, which are devoted to the study of damage to the cardiovascular system as a result of COVID-19 affection. Materials and Methods. Publications were selected using keywords in PubMed (https://pubmed.ncbi.nlm.nih.gov/) and Google Scholar (https://scholar.google.com/) databases published over the period from 2020 to 2022. Results. The article analyzes the existing data of meta-analyzes regarding the incidence of cardiovascular disease, the effect of diabetes mellitus on the course of the disease, existing theories of the pathogenesis of cardiovascular disease in COVID-19. Clinical variants of heart damage in COVID-19 are also given, which are described in the literature today. Particular attention is paid to the peculiarities of development and the course of postcoid myocarditis, which is one of the most common complications of COVID-19 on the part of the cardiovascular system. Particularly noteworthy is the fact that according to the literature, some patients were diagnosed with myocarditis without clinical manifestations. Therefore, the data of histological examination of the myocardium of COVID-19 patients without myocarditis symptoms are of great interest. Difficulties also arise at the stage of diagnosing myocarditis, because the currently accepted methods are sometimes uninformative. Mass vaccination against COVID-19, unfortunately, also had such undesirable side effects as post-injection myocarditis. The literature data on the development of dilated cardiomyopathy after suffering from COVID-19 are presented. At the same time, dilated cardiomyopathy can be the result not only of the transferred myocarditis, but also a primary reaction to the effect of cytokines released by the virus. Conclusions. COVID-19 can exacerbate pre-existing cardiovascular pathology and provoke acute myocardial injury, deteriorating the course of the disease and the life prognosis for the patient.

Стилі APA, Harvard, Vancouver, ISO та ін.

32

De Freitas, Anderson Louis Gomes Cavalcante, Martilianno Silva Santos, and José André Bernardino Dos Santos. "Complicações vasculares pós covid-19 / Vascular complications after covid-19." Brazilian Journal of Health Review 4, no. 3 (June 14, 2021): 13090–105. http://dx.doi.org/10.34119/bjhrv4n3-262.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Kulbayeva, Zeine, Dmitriy Klyuyev, and Sholpan Kaliyeva. "Neurological symptoms and complications of COVID-19. Minireview." Bulletin of the Karaganda University. “Biology, medicine, geography Series” 104, no. 4 (December 30, 2021): 110–16. http://dx.doi.org/10.31489/2021bmg4/110-116.

Повний текст джерела

Анотація:

Since the first official case of COVID-19 in China in December 2019, researchers have been trying to uncover the mechanism of action of the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), which attacks several organs in addition to the lungs and causes circulatory changes that can lead to death not only because of lung failure but also failure of other organs. The aim of this study is to find out the neurological consequences of COVID-19. A systematic review of the literature was concretized by mobilizing the descriptors: “SARS-CoV-2”, “coronavirus infections” and “Neurological Consequences”. Although the effects of SARSCoV-2 on the lung are exemplary and frightening, the long-term effects on the nervous system may be greater and even more overwhelming, as the regeneration of nerve tissue is difficult and can lead to general disability, as the nervous system coordinates the functions of the entire body. Considered studies point out the presence of various injuries (mild or severe) to central nervous system because of COVID-19 infection. It can be said that the studies all agree on the possibility of existing neurological sequelae and a majority emphasize on the need for further investigation.

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Kamilov, Khalidjan, Munirakhon Kasimova, Gavkhar Khamraeva, and Manzurakhon Rizaeva. "INFECTIOUS AND INFLAMMATORY COMPLICATIONSIN OPHTHALMOLOGYAMID COVID-19." UZBEK MEDICAL JOURNAL 2, no. 5 (May 30, 2021): 40–44. http://dx.doi.org/10.26739/2181-0664-2021-5-8.

Повний текст джерела

Анотація:

Inflammatory complications of the organ of vision in the time of COVID-19 can be manifested as conjunctivitis, scleritis, episcleritis, keratitis, uveitis and optic neuritis. It is essential to collect anamnesis, examine the blood for the presence of COVID 19 and treat these patients with the help of infectious disease specialists. Correct diagnosis of inflammatory ocular complications in the presence of COVID 19 makes it possible to prevent ocular complications, such as: ulcers and corneal penetration; fusion and overgrowth of the pupil,which leadto secondary glaucoma; endoophthalmitis, panophthalmitis and optic nerve atrophy. Timely intensive medical care and adequate treatment of these complications lead to a decrease in disability in this category of patients.Keywords:Ophthalmology, COVID-19,complications, ulcers, endoophthalmitis, panophthalmitis, gastrointestinal tract, cavernous sinus thrombosis

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Johnson, Kasey B., Vanessa G. Carroll, and Hinah G. Parker. "Pneumomediastinum After COVID-19." Global Pediatric Health 9 (January 2022): 2333794X2211017. http://dx.doi.org/10.1177/2333794x221101773.

Повний текст джерела

Анотація:

A preadolescent female presented to the emergency department with an acute asthma exacerbation. Chest radiograph and computed tomography scan showed extensive pneumomediastinum with a small pneumopericardium without a distinct source for this air leak. The patient was admitted for noninvasive monitoring, analgesia, and high concentration oxygen. Serial chest radiographs showed marked improvement following high concentration oxygen, and she was discharged on hospital day 3. Spontaneous pneumomediastinum and pneumopericardium are rare complications of asthma that can often be managed conservatively but should be considered on the differential for this patient population, and may be a complication of COVID-19.

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Basu, Debdoot, Vivek P. Chavda, and Anita A. Mehta. "Therapeutics for COVID-19 and post COVID-19 complications: An update." Current Research in Pharmacology and Drug Discovery 3 (2022): 100086. http://dx.doi.org/10.1016/j.crphar.2022.100086.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Alderton, Gemma. "COVID-19 complications in South Africa." Science 369, no. 6502 (July 23, 2020): 387.9–389. http://dx.doi.org/10.1126/science.369.6502.387-i.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Marian, Ali J. "Editorial: Cardiovascular complications of COVID-19." Current Opinion in Cardiology 36, no. 3 (February 16, 2021): 253–55. http://dx.doi.org/10.1097/hco.0000000000000846.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Desai, Amar D., Michael Lavelle, Brian C. Boursiquot, and Elaine Y. Wan. "Long-term complications of COVID-19." American Journal of Physiology-Cell Physiology 322, no. 1 (January 1, 2022): C1—C11. http://dx.doi.org/10.1152/ajpcell.00375.2021.

Повний текст джерела

Анотація:

SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of people worldwide. As our experience with this virus continues to grow, our understanding of both short-term and long-term complications of infection with SARS-CoV-2 continues to grow as well. Just as there is heterogeneity in the acute infectious phase, there is heterogeneity in the long-term complications seen following COVID-19 illness. The purpose of this review article is to present the current literature with regards to the epidemiology, pathophysiology, and proposed management algorithms for the various long-term sequelae that have been observed in each organ system following infection with SARS-CoV-2. We will also consider future directions, with regards to newer variants of the virus and their potential impact on the long-term complications observed.

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Li, Linling, Ruitao Zhang, Fang Li, Chufan Xiao, Bowen Zhong, Shiyao Zhai, Changyue Liu, et al. "COVID-19 Pulmonary and Extrapulmonary Complications." Journal of Biosciences and Medicines 10, no. 03 (2022): 152–74. http://dx.doi.org/10.4236/jbm.2022.103016.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Pawar, Neelam, Devendra Maheshwari, Meenakshi Ravindran, and S. Padmavathy. "Ophthalmic complications of COVID-19 vaccination." Indian Journal of Ophthalmology 69, no. 10 (2021): 2900. http://dx.doi.org/10.4103/ijo.ijo_2122_21.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Pawar, Neelam, Devendra Maheshwari, Meenakshi Ravindran, and S. Padmavathy. "Ophthalmic complications of COVID-19 vaccination." Indian Journal of Ophthalmology 69, no. 10 (2021): 2900. http://dx.doi.org/10.4103/ijo.ijo_2122_21.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Roman, Gustavo. "The neurologic complications of COVID-19." Journal of the Neurological Sciences 429 (October 2021): 117876. http://dx.doi.org/10.1016/j.jns.2021.117876.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Rageh, Tarek, Moustafa Othman, Mohamed El-Barody, and Ahmed Nasreldein. "Atypical cerebrovascular complications of COVID-19." Journal of the Neurological Sciences 429 (October 2021): 119880. http://dx.doi.org/10.1016/j.jns.2021.119880.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Trêpa, Maria Ana, António Hipólito Reis, and Mario Oliveira. "Cardiovascular Complications of COVID-19 Infection." Acta Médica Portuguesa 34, no. 9 (August 31, 2021): 608. http://dx.doi.org/10.20344/amp.15584.

Повний текст джерела

Анотація:

Introduction: Reports of cardiovascular complications related to the COVID-19 infection have been frequent.Methods: Narrative review for relevant articles on the topic. The classic cardiovascular risk factors, like age, obesity, diabetes, and hypertension are associated with adverse outcomes in COVID-19 patients. Cardiovascular complications can have a diverse clinical presentation including silent myocardial injury, acute coronary syndromes, thromboembolism, cardiac arrhythmias, and heart failure. There are multiple mechanisms of cardiac injury that are not mutually exclusive. The approach to diagnosis and management should be carried out according to usual practice, while considering the particularities of COVID-19 infection.Conclusion: The interaction between SARS-CoV-2 and the heart is complex and is manifested in multiple ways. Regardless of the clinical presentation, cardiac complications convey a worse prognosis. Patients should be actively monitored and treated accordingly.

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Castro, Rebecca A., and William H. Frishman. "Thrombotic Complications of COVID-19 Infection." Cardiology in Review 29, no. 1 (September 17, 2020): 43–47. http://dx.doi.org/10.1097/crd.0000000000000347.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Meiler, Stefanie, and Okka W. Hamer. "Thromboembolic Complications in COVID-19 Pneumonia." Journal of Vascular and Interventional Radiology 31, no. 9 (September 2020): 1426. http://dx.doi.org/10.1016/j.jvir.2020.06.006.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Mensah, George A., Muthiah Vaduganathan, and Gregory A. Roth. "Acute Cardiovascular Complications of COVID-19." Journal of the American College of Cardiology 81, no. 6 (February 2023): 570–73. http://dx.doi.org/10.1016/j.jacc.2022.11.042.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Randhawa, S., and A. Alsamarrai. "Cardiac Complications of COVID-19 Infection." Heart, Lung and Circulation 32 (June 2023): S82. http://dx.doi.org/10.1016/j.hlc.2023.04.226.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Lee, S., S. Randhawa, A. Alsamarrai, and J. Somaratne. "Cardiac Complications of COVID-19 Infection." Heart, Lung and Circulation 32 (July 2023): S271—S272. http://dx.doi.org/10.1016/j.hlc.2023.06.351.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Статті в журналах з теми "COVID-19 – complications"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями